Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
Lipid characteristics in metastatic cells
Authors
Salvatore Ruggieri
Gabriele Mugnai
Antonella Mannini
Lido Calorini
Anna Fallani
Emanuela Barletta
Gianna Mannori
Oliviero Cecconi
Publication date
01-06-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 4/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006662811948

Other articles of this Issue 4/1999

Clinical & Experimental Metastasis 4/1999 Go to the issue

OriginalPaper

Increased levels of α6 integrins are associated with the metastatic phenotype of human breast cancer cells

OriginalPaper

Cure of colon cancer metastasis in rats with the new lipid A OM 174. Apoptosis of tumor cells and immunization of rats

OriginalPaper

Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids

OriginalPaper

Scatter factor influences the formation of prostate epithelial cell colonies on bone marrow stroma in vitro

OriginalPaper

Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer

OriginalPaper

Role of neurotrophins and neurotrophin receptors in the in vitro invasion and heparanase production of human prostate cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits